Board of Directors

BASUDEV N SINGH

Director

Mr. Basudev N. Singh is co-founder of Alkem Laboratories Ltd and is director on Enzene Board.

He has over four decades of experience in the Indian pharmaceutical industry. He was the recipient of ‘Business Leader of the Year 2014’ at the 7th Annual Pharmaceutical Leadership Summit and the Pharma Leaders Business Leadership Awards 2014. He was also named ‘EY Entrepreneur of the Year in Life Sciences’ in the year 2016. In the period extending 2007 – 2009, Mr. Singh had a stint as President of the Indian Drug Manufacturers’ Association.

Recently, he was named ‘Chief Mentor of the Year’ by the Indian Drug Manufacturers’ Association.

SANDEEP SINGH

Director

Mr. Sandeep Singh is Managing Director of Alkem Laboratories Ltd. He has over 17 years of experience in the pharmaceutical industry. He spearheads the domestic as well as the international operations. Alkem wanted to enter into a Biotech Space, hence, Sandeep was instrumental in the acquisition of Enzene into the Alkem Group and has been a strong influencer in nurturing and growing Enzene into an independent biotech company.

As an entrepreneur he is very passionate about innovation, and how they can create new opportunities. He is ardent about Plant-Based Food and Biotech. He has been instrumental in establishing multiple initiatives in this space.

In the year 2016, he was presented with the ‘Emerging Pharma Leader of 2016 Award’ by the Pharma Leaders in association with the Ministry of Health & Family Affairs, Government of India. He is also featured in The Economic Times 2020 edition 40 under 40 listing which honors 40 of brightest corporate leaders, entrepreneurs and owner professionals under the age of 40 across India.

HIMANSHU GADGIL, PhD

CEO

Dr. Himanshu Gadgil currently holds the position of CEO at Enzene Biosciences Ltd. During his tenure, Enzene has evolved from a startup biotech venture into a biopharmaceutical company with a diverse range of verticals and locations, specializing in product development and manufacturing services. Before joining Enzene, he served as the Senior Vice President at Intas Pharmaceutical Ltd. There, he played a pivotal role in revitalizing the commercial product pipeline by successfully introducing numerous biosimilar products across various global markets. During his time in the United States, he led various aspects of process and product development at Amgen, actively participating in achieving regulatory approvals for several groundbreaking biotech products through processes like IND, BLA, and Market authorizations. Early in his career, he embarked at Waters Corporation, where he spearheaded the development of Quality by Design (QBD) methodologies, pioneering the creation of multi-attribute approaches for biopharmaceutical characterization. Himanshu’s educational background includes a PhD in Biochemistry from the University of Tennessee. With a remarkable portfolio of over 50 publications and patents, he is not only a dedicated scientific leader but also a passionate innovator.

Amit Ghare

Director

Mr. Amit Ghare is a Bachelor of Engineering and holds a Master’s Degree in Business Administration. He has a vast experience in areas of international sales, corporate planning and strategic management. He has been associated with the management of Alkem Labs since 2011 and is working as President-International Business for Alkem Laboratories Ltd.

SUDHA RAVI

Independent Director

She is working as an advisor with Piramal Capital & Housing Finance Ltd., the merged entity of Piramal Finance Ltd. with Piramal Housing Finance Ltd. From October 2014, she is also, in-charge of India Venture Advisors Pvt. Ltd. – a healthcare and life sciences focused private equity fund sponsored by the Piramal Group. Before joining the Piramal Group in 2011, Ms. Ravi was associated with State Bank of India (SBI) for over 30 years. She started her journey in SBI as a Probationary Officer in 1978. During her stint at SBI, she held several important portfolios and was stationed across the length and breadth of the country. She has worked in different verticals such as International, Corporate, Retail and Rural banking, which gave her an unparalleled expertise in the financial sector and business strategy.

Ms. Sudha Ravi became a member of the Alkem’s Board in the year 2015.

She has held key positions like General Manager, Enterprise Risk Management where she facilitated the alignment of risk with strategy at the bank-wide level and as Chief Representative, Washington DC, USA. For outstanding contribution in the sphere of banking for community in Washington DC, she has received several recognitions/plaques by various Indian associations based in United States. Ms. Ravi has a keen interest in the education of autistic children.

Ms. Sangeeta K. Singh

Independent Director

Ms. Sangeeta K Singh has over 35 years of experience in Human Resources, Communications and Operations. She was previously a Partner & Head of Human Resources in KPMG India. She holds a Master Degree in Behavioural Psychology and certification in Strategic Human Resource Management from Harvard Business School. She serves as an Independent Director on the boards of several renowned companies.

Prem Pavoor

Non-Executive Nominee Director

Prem Pavoor is Senior Partner, Head of India and India Healthcare Ventures at Eight Roads Ventures, the proprietary investment arm of Fidelity International, and leads investments in India in life sciences, healthcare and healthcare information technology.

Prem was previously based in the United States with McKinsey & Company’s Pharmaceutical and Medical Products Practice where he advised pharmaceutical, consumer healthcare and private equity firms on areas including R&D, business development, manufacturing optimisation and post-merger integrations.

His doctoral thesis work at the Massachusetts Institute of Technology (MIT) and Harvard Medical School focused on implantable medical devices and novel nano-coatings. Prem is the lead author of several scientific publications, the named inventor on two US patents, and was awarded the 2004 MIT-OMNOVA Award for Excellence in Polymer Research and Technology.

Prem holds a Bachelor’s degree in Chemical Engineering from the Institute of Chemical Technology (formerly UDCT), Mumbai, a MS and Ph.D. in Chemical Engineering Practice from MIT and an MBA from MIT Sloan.